COMMUNIQUÉS West-GlobeNewswire

Pharming Group announces the placement of €100 million convertible bonds due 2029
18/04/2024
NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. Leiden, the Netherlands [...]
Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
18/04/2024
SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that the [...]
Hapbee Announces Closing of Private Placement
18/04/2024
Company Raises $2.8 Million From Qualified Investors to Fund Product Development, Market Expansion and Manufacturing VANCOUVER, British Columbia, April 18, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies , Inc. (TSXV: HAPB [...]
Precision Optics Announces Receipt of $720,000 Follow-On Production Order from Top Tier Defense/Aerospace Customer for New Optical Application
18/04/2024
GARDNER, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today [...]
Digital Utilities Ventures Completes Strategic Merger - Paving the Way for Future Growth and Innovation
18/04/2024
MANKATO, Minn., April 18, 2024 (GLOBE NEWSWIRE) -- Digital Utilities Ventures, Inc. (OTC: DUTV) is pleased to announce the successful completion of its acquisition of Easy Energy Systems Technologies, LLC and Easy [...]
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
18/04/2024
SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the commercial availability [...]
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
18/04/2024
OCALA, Fla., April 18, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website. For the CEO [...]
Ultimovacs ASA – Annual General Meeting held on April 18, 2024
18/04/2024
Oslo, April 18, 2023: Ultimovacs ASA held its annual general meeting today April 18, 2024. All the matters on the agenda were approved. The following board members were re-elected for a period of one year, and the Board [...]
Korro Announces $70 Million Private Placement
18/04/2024
Financing led by Deep Track Capital with participation from other leading healthcare investors Pro-forma cash and cash equivalents of approximately $236 million before fees and expenses On track for regulatory filing [...]
Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives
18/04/2024
ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and [...]
IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101
18/04/2024
Company expects enrollment in Phase 1 proof-of-concept study of DNA-based vaccine technology to begin in the second quarter LAWRENCEVILLE, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- IMUNON , Inc. (NASDAQ: IMNN) , a [...]
Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results
18/04/2024
Year-over-year unaudited revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024, with highest quarterly cartridge sales since 2022 Intelligent Fingerprinting acquisition NEW [...]
Lexicon Pharmaceuticals to Host 2024 Investor Day
18/04/2024
Includes Business and Scientific Updates from Lexicon Executives and Leading Medical Experts in Hypertrophic Cardiomyopathy, Type 1 Diabetes and Diabetic Peripheral Neuropathic Pain THE WOODLANDS, Texas, April 18, 2024 [...]
BiomX Announces the Appointment of Susan Blum to its Board of Directors
18/04/2024
CAMBRIDGE, Mass. and NESS ZIONA, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies [...]
Windtree Therapeutics Announces Reverse Stock Split
18/04/2024
WARRINGTON, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NASDAQ: WINT) (“Windtree” or the “Company”), a biotechnology company focused on advancing early and late-stage innovative therapies for [...]
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation
18/04/2024
Additionally, the Company announced approval of the non-proprietary name “bezisterim” for NE3107 CARSON CITY, Nev., April 18, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical- [...]
Montauk Brewing’s Project 4:20 IPA Returns to Support Surfrider Foundation
18/04/2024
Proceeds Will Help Protect Oceans, Waves and Beaches for All People to Enjoy MONTAUK, N.Y., April 18, 2024 (GLOBE NEWSWIRE) -- Montauk Brewing Company (“Montauk Brewing” or “Montauk”), the leading and fastest-selling [...]
Canadian Men's Health Foundation names Kenton Boston as President & CEO
18/04/2024
VANCOUVER, British Columbia, April 18, 2024 (GLOBE NEWSWIRE) -- The Canadian Men’s Health Foundation ’s (CMHF) board of directors is proud to announce the appointment of Kenton Boston as President & Chief Executive [...]
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
18/04/2024
WILMETTE, Ill., April 18, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced [...]

Pages